** GlaxoSmithKline rises to trade up 4.2 pct afterQ3 earnings beat consensus
** Q3 core EPS 23p v 19.3p expected by analysts, accordingto Thomson Reuters data
** Top riser on FTSE 100 with pharma peers alsohigher
** AstraZeneca up 2 pct
(RM: alasdair.pal.thomsonreuters.com@reuters.net)